WO2009103427A3 - Use of 3-(4-hydroxy-3-methoxyphenyl)-1(4-hydroxyphenyl)-propane-1-on against hyperpigmentation - Google Patents

Use of 3-(4-hydroxy-3-methoxyphenyl)-1(4-hydroxyphenyl)-propane-1-on against hyperpigmentation Download PDF

Info

Publication number
WO2009103427A3
WO2009103427A3 PCT/EP2009/000785 EP2009000785W WO2009103427A3 WO 2009103427 A3 WO2009103427 A3 WO 2009103427A3 EP 2009000785 W EP2009000785 W EP 2009000785W WO 2009103427 A3 WO2009103427 A3 WO 2009103427A3
Authority
WO
WIPO (PCT)
Prior art keywords
methoxyphenyl
hydroxyphenyl
propane
hydroxy
hyperpigmentation
Prior art date
Application number
PCT/EP2009/000785
Other languages
German (de)
French (fr)
Other versions
WO2009103427A2 (en
Inventor
Stefanie Knaupmeier
Christoph Smuda
Ludger Kolbe
Julia Eckert
Gitta Neufang
Nils Peters
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Publication of WO2009103427A2 publication Critical patent/WO2009103427A2/en
Publication of WO2009103427A3 publication Critical patent/WO2009103427A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to the use of 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-propane-1-on in cosmetic or dermatological preparations for treating and preventing hyperpigmentation and for alleviating post-inflammatory pigmentation disorders.
PCT/EP2009/000785 2008-02-18 2009-02-05 Use of 3-(4-hydroxy-3-methoxyphenyl)-1(4-hydroxyphenyl)-propane-1-on against hyperpigmentation WO2009103427A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008009799.3 2008-02-18
DE102008009799.3A DE102008009799B4 (en) 2008-02-18 2008-02-18 Use of 3- (4-hydroxy-3-methoxyphenyl) -1- (4-hydroxyphenyl) -propan-1-one against hyperpigmentation

Publications (2)

Publication Number Publication Date
WO2009103427A2 WO2009103427A2 (en) 2009-08-27
WO2009103427A3 true WO2009103427A3 (en) 2009-11-19

Family

ID=40874094

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/000785 WO2009103427A2 (en) 2008-02-18 2009-02-05 Use of 3-(4-hydroxy-3-methoxyphenyl)-1(4-hydroxyphenyl)-propane-1-on against hyperpigmentation

Country Status (3)

Country Link
CN (1) CN101524315A (en)
DE (1) DE102008009799B4 (en)
WO (1) WO2009103427A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2974300B1 (en) * 2011-04-19 2013-05-10 Inneov Lab USE OF A COMBINATION OF A CAROTENOID, A PHYTOESTROGEN AND VITAMIN C FOR THE PREVENTION AND / OR TREATMENT OF PIGMENT DISORDERS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11236328A (en) * 1997-12-16 1999-08-31 Mitsui Chem Inc Cosmetic comprising hydrochalcone derivative and/or chalcone derivative as active ingredient
WO2009013168A1 (en) * 2007-07-25 2009-01-29 Symrise Gmbh & Co. Kg 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone and its use as antioxidant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4308282C2 (en) 1993-03-16 1994-12-22 Beiersdorf Ag Galenic matrices preferably in the form of microspheres
EP1818060A1 (en) * 2005-11-23 2007-08-15 ARTSANA S.p.A. Cosmetic composition comprising Fadogia ancylantha extracts
EP1977655B1 (en) * 2007-03-29 2011-05-18 Symrise AG Aroma compositions of alkamides with hesperetin and/or 4-hydroxydihydrochalkones and their salts for reinforcing sweet sensory impressions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11236328A (en) * 1997-12-16 1999-08-31 Mitsui Chem Inc Cosmetic comprising hydrochalcone derivative and/or chalcone derivative as active ingredient
WO2009013168A1 (en) * 2007-07-25 2009-01-29 Symrise Gmbh & Co. Kg 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone and its use as antioxidant

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KHATIB S ET AL: "Chalcones as potent tyrosinase inhibitors: the importance of a 2,4-substituted resorcinol moiety", BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER SCIENCE LTD, GB, vol. 13, no. 2, 17 January 2005 (2005-01-17), pages 433 - 441, XP004681527, ISSN: 0968-0896 *
LIN ET AL: "Constituents from the Formosan apple reduce tyrosinase activity in human epidermal melanocytes", PHYTOCHEMISTRY, PERGAMON PRESS, GB, vol. 68, no. 8, 6 April 2007 (2007-04-06), pages 1189 - 1199, XP022023215, ISSN: 0031-9422 *

Also Published As

Publication number Publication date
WO2009103427A2 (en) 2009-08-27
DE102008009799A1 (en) 2009-08-20
CN101524315A (en) 2009-09-09
DE102008009799B4 (en) 2017-07-20

Similar Documents

Publication Publication Date Title
WO2006087759A3 (en) Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field
MX2009011743A (en) Dermatological and cosmetic depigmenting compositions, methods for the preparation thereof and uses thereof.
GB2465703B (en) Cosmetic treatment using p-coumaric acid derivatives for the reduction of skin pigmentation
EP2234594A4 (en) Compositions and methods for treating skin with extract from trametes
WO2010083368A3 (en) Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions
EP2295028A4 (en) Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method
WO2008137633A3 (en) Methods of modulating cellular homeostatic pathways and cellular survival
EP2250998A4 (en) Skin whitening agent and external preparation for the skin
HK1149322A1 (en) Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
HK1164709A1 (en) Combination of lycopene, polyphenol, and vitamins for the care of keratin material
EP2063859A4 (en) Cosmetic composition for the treatment of skin and methods thereof
EP2244690A4 (en) Methods and compositions for treating dermatological diseases and conditions
WO2009141541A3 (en) Use of kif13a and ap-1 inhibitors for inhibiting melanogenesis
WO2008107092A3 (en) Use of derivatives of 4-hydroxyphenoxy acetic acid
HK1141454A1 (en) A cosmetic composition for skin whitening comprising the extract of magnolia sieboldii as active ingredient
GB0719202D0 (en) Compositions and methods for the skin and hair
ZA201104079B (en) Therapeutic,dietary,or cosmetic use of compounds with specific anti-apoptotic activity toward caspase-3,and compositions containing these compounds
WO2010015965A3 (en) Methods and compositions for treating neuronal damage and modulating transient receptor potential channels
EP2120994A4 (en) Methods and compositions for treating hypoglycemic disorders
PT2331057T (en) Compositions and methods for modulating skin pigmentation
IL200570A0 (en) Combination therapy, composition and methods for the treatment of cardiovascular disorders
EP2224937A4 (en) Composition for preventing and treating metabolic diseases comprising the extract of lysimachiae foenum-graeci herba
EP2214634A4 (en) Skin moisturizer, blood circulation promoter, and external preparations for the skin containing the skin moisturizer and the blood circulation promoter
WO2009103427A3 (en) Use of 3-(4-hydroxy-3-methoxyphenyl)-1(4-hydroxyphenyl)-propane-1-on against hyperpigmentation
WO2010007494A3 (en) New composition for the treatment of ecchymotic pigmentations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09712301

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09712301

Country of ref document: EP

Kind code of ref document: A2